WEILAND JOHN H 4

What Happened John H. Weiland, a director of Solventum Corp (SOLV), was granted 3,300 restricted stock units (RSUs) on May 15, 2026. The award is recorded at $0.00 per unit (derivative award); each RSU represents the contingent right to receive one share of common stock upon settlement. This is a compensation/award transaction rather than an open-market purchase or sale.

Key Details

• Transaction date: May 15, 2026; filing date: May 18, 2026 (filed within the Form 4 two-business-day deadline).
• Grant details: 3,300 RSUs granted, acquisition price reported as $0.00 (derivative).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnotes: F1 — each RSU equals a contingent right to 1 share on settlement; F2 — RSUs vest in full on May 15, 2027, subject to continued service.
• No indication this was a sale, tax withholding, or 10b5-1 plan.

Context RSU grants are common director/executive compensation intended for retention; they do not immediately put shares into the market. These RSUs will convert to actual shares only if the vesting condition (continued service through May 15, 2027) is met. For retail investors, awards signal compensation alignment but are not the same bullish signal as an insider buying shares with personal funds.